Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotectionHojin Kang, Joo‐Ho Shin, Sun Ha Paek et al.|Oncotarget|2017Cited by 70
PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseAreum Jo, Joo‐Ho Shin, Yunjong Lee et al.|Science Translational Medicine|2021Cited by 64
PARIS reprograms glucose metabolism by HIF-1α induction in dopaminergic neurodegenerationHojin Kang, Joo‐Ho Shin, Areum Jo et al.|Biochemical and Biophysical Research Communications|2017Cited by 26
Diaminodiphenyl sulfone–induced parkin ameliorates age-dependent dopaminergic neuronal lossYun‐Il Lee, Joo‐Ho Shin, Hojin Kang et al.|Neurobiology of Aging|2015Cited by 19
Identification of transketolase as a target of PARIS in substantia nigraHye-In Kim, Joo‐Ho Shin, Hojin Kang et al.|Biochemical and Biophysical Research Communications|2017Cited by 14